DEVELOPING INNOVATIVE NUTRACEUTICAL TECHNOLOGIES
The Biologic mission is to be at the forefront of research and development of natural health care; to educate both health care professionals and consumers regarding treatment and preventive protocols; to make alternative and complementary health care and performance-enhancing nutrition available and supported by research.
Our mission is to found irrefutable science that facilitates the acceptance of modern medicine and to contribute irrefutable science to education and instruction.
WHAT WE DO
We provide reliable, up-to-date scientific reporting to medical professionals (scientific language) and consumers (layman terms).
We produce easy to read scientific-based education and instruction related to health maintenance and restoration, performance-enhancement, and weight management for consumers.
Nutrigenomics, the study of NUTRIENT-GENE interactions, is the discipline that will weld allopathic and naturopathic endeavors. Our directive at Biologic has unveiled and continues to reveal irrefutable science for complementary health care.
Biologic is dedicated to the advancement and standardized commercialization of science-supported natural compounds.
Our core-patented, natural technologies are engineered to support mind, body, and metabolism with peer-reviewed published research which supports pharmacology and claims.
Founder and Author Franco Cavaleri has published several internationally acclaimed best-selling books on human and pet health, presenting the latest research on nutraceutical and nutrition-based health management and preservation.
Why study natural medicines in the context of current pharmaceutical models?
Allopathic medicine centers on drug selectivity to improve drug effectiveness and reduce drug side-effects and contraindications. Such selectivity also plays a supportive role in patent viability and drug reliability. Natural compounds, even if isolated and concentrated are often comprised of sub-fractions that can contribute to a polypharmacology that does not fit the selectivity model.
In order to better predict the biological activity and potential interactivity of these multi-factorial natural medicinal agents, the sub-fractions common to the natural extracts need to be studied individually as sequestered molecules and characterized in isolation.
This compartmentalized information allows us to better understand the complex activity of the extract in its natural form but it also allows us an opportunity to splice out a specific activity that is more selective for a desired membrane, cytoplasmic or nuclear target. With this information, we gain the knowledge of the underpinnings for improved drug design with natural agents – the isolated fractions and/or their combinations.